National Cipla, Hetero get DCGI’s nod to launch Remdesivir forCovid-19 treatment Cheena Khanna Jun 21, 2020 India's Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir for treatment of Covid-19 Patients on Oxygen Support
